Stay updated on ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.

Latest updates to the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a backend/version update with no changes to study content or presented data.SummaryDifference0.1%

- Check13 days agoChange DetectedUI/layout adjustments are visible, including revised header and panel formatting; no substantive study data or site information appear to have changed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedNCT02880956 results were posted, including primary and secondary efficacy outcomes (e.g., CDR-SB, ADAS-Cog-14, ADCOMS) and safety data. The update adds detailed numerical results and related safety information to the Study Details page.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page shows a new site revision (Revision: v3.4.2) has been added, and the funding lapse notice along with Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a site-wide government funding notice indicating possible delays and open status (cc.nih.gov and opm.gov references) and updated the system revision to v3.4.1, replacing the previous v3.4.0 note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedShow glossary option added; capitalization tweaks for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; revision updated to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.